VIVIMEDLAB — Vivimed Labs Income Statement
0.000.00%
Last trade - 00:00HealthcareBalancedMicro Cap
Annual income statement for Vivimed Labs, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 8,615 | 2,373 | 1,871 | 1,491 | 1,163 |
| Cost of Revenue | |||||
| Gross Profit | 3,671 | 580 | -1,145 | 619 | 564 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 8,577 | 2,636 | 4,824 | 1,742 | 1,495 |
| Operating Profit | 38 | -263 | -2,953 | -251 | -333 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -699 | -648 | -3,307 | -458 | -318 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -719 | -677 | -3,285 | -454 | -320 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -719 | -677 | -3,285 | -454 | -320 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -719 | -677 | -3,285 | -454 | -320 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -8.67 | -8.16 | -32.6 | -3.37 | -3.85 |